Assessment of mean platelet volume in chronic obstructive pulmonary disease during stable period and acute exacerbation

• Published in: Journal of clinical and experimental investigations 2013-12, Vol.4 (4), p.483
• Main Authors: Erden, Ersin Şükrü, Dokuyucu, Recep, Demirköse, Mesut, Yengil, Erhan, Sefil, Fatih, Bilgiç, Hatice Kayım, Doğru, Sibel, Motor, Sedat
• Format: Article
• Language: English
• Subjects: Chronic obstructive pulmonary disease
• ISSN: 1309-6621; 1309-6621
• DOI: 10.5799/ahinjs.01.2013.04.0329

Objective: Chronic obstructive pulmonary disease (COPD) is an important public health problem and it is associated with systemic inflammation. Mean platelet volume (MPV) is one of the markers indicating platelet activation, and it was found to be high in many diseases related to inflammation. In previous studies reported different results evaluating of MPV in COPD. In this study, we aimed to evaluate of C-reactive protein (CRP), white blood cell (WBC), and MPV in acute exacerbation of COPD and stable COPD patients. Methods: In this retrospective study, data of 40 patients with acute exacerbation of COPD, 43 stable COPD patients and 40 healthy subjects were evaluated. Results: The mean MPV, CRP and WBC were found in control, stable COPD and acute exacerbation of COPD groups, 7.9±1.1; 8.2±1.3 and 8.7±1.6 fL; 3.4±1.2; 5.2±3.5 and 27.5±23.6 mg/L; 7.8±1.6; 8.1±2.1 and 11.4±4.5 x103/ ϻL, respectively. The mean WBC and CRP in the acute exacerbation of COPD group were significantly higher than the other groups (for both values p ˂0.001). The mean MPV in the acute exacerbation of COPD group was found higher than in the other groups. The mean MPV values were significantly higher in patients of acute exacerbation than control subjects (p=0.030). Conclusion: The results of this study suggest that the increased MPV may be a marker for the evaluation acute exacerbation of COPD as well as the classic acute phase reactant CRP.